89R11882 SCF-D
 
  By: Bucy H.B. No. 2412
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to health benefit plan coverage for certain obesity
  medications.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 1369, Insurance Code, is amended by
  adding Subchapter R to read as follows:
  SUBCHAPTER R.  COVERAGE FOR CERTAIN OBESITY MEDICATIONS
         Sec. 1369.781.  APPLICABILITY OF SUBCHAPTER. (a) This
  subchapter applies only to a health benefit plan that provides
  benefits for medical or surgical expenses incurred as a result of a
  health condition, accident, or sickness, including an individual,
  group, blanket, or franchise insurance policy or insurance
  agreement, a group hospital service contract, or an individual or
  group evidence of coverage or similar coverage document that is
  issued by:
               (1)  an insurance company;
               (2)  a group hospital service corporation operating
  under Chapter 842;
               (3)  a health maintenance organization operating under
  Chapter 843;
               (4)  an approved nonprofit health corporation that
  holds a certificate of authority under Chapter 844;
               (5)  a multiple employer welfare arrangement that holds
  a certificate of authority under Chapter 846;
               (6)  a stipulated premium company operating under
  Chapter 884;
               (7)  a fraternal benefit society operating under
  Chapter 885;
               (8)  a Lloyd's plan operating under Chapter 941; or
               (9)  an exchange operating under Chapter 942.
         (b)  Notwithstanding any other law, this subchapter applies
  to:
               (1)  a basic coverage plan under Chapter 1551;
               (2)  a basic plan under Chapter 1575;
               (3)  a primary care coverage plan under Chapter 1579;
  and
               (4)  the state Medicaid program, including the Medicaid
  managed care program operated under Chapter 540, Government Code.
         Sec. 1369.782.  COVERAGE REQUIRED FOR CERTAIN OBESITY
  MEDICATIONS. A health benefit plan that provides prescription drug
  benefits must provide coverage for a prescription drug that is a
  glucagon-like peptide-1 receptor agonist to treat obesity.
         SECTION 2.  If before implementing any provision of this Act
  a state agency determines that a waiver or authorization from a
  federal agency is necessary for implementation of that provision,
  the agency affected by the provision shall request the waiver or
  authorization and may delay implementing that provision until the
  waiver or authorization is granted.
         SECTION 3.  Subchapter R, Chapter 1369, Insurance Code, as
  added by this Act, applies only to a health benefit plan delivered,
  issued for delivery, or renewed on or after January 1, 2026.
         SECTION 4.  This Act takes effect September 1, 2025.